ArticleF1000Research2025
Accuracy of Systemic Inflammatory Indices in Identifying Neonatal Sepsis in Preterms in a Tertiary Care Hospital in Mangalore.
Article in F1000Research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The utility of Systemic Inflammatory Indices as accurate indicators of neonatal sepsis remains underexplored in the Indian population. This study will assist in determining whether these indices can be used to predict neonatal sepsis at the bedside and as an early sensitive predictor of sepsis in preterms. Methods: A prospective case-control study was done, where the Systemic Inflammatory Indices of the two groups of preterms - one control group without sepsis and one case group with culture proven sepsis-were compared to assess their value in predicting Neonatal Sepsis. Data from 138 preterm neonates were used in the present study. Six Systemic Inflammatory Indices were calculated - Systemic Immune Inflammatory Index (SII), Systemic Inflammation Response Index (SIRI), PanImmune Inflammation Value (PIV), Neutrophil to Lymphocyte Ratio (NLR), Platelet to Lymphocyte Ratio (PLR) and Monocyte to Lymphocyte Ratio (MLR). These values from both the case and control groups were compared. Results: Platelet count had the highest predictive value, with an AUC value of 0.715(95% CI 0.628-0.802, p<0.001) and optimal cut-off value of 219500 cells/cu mm. It had a sensitivity of 75.4 and specificity of 65.2. PIV had an AUC of 0.665(95% CI 0.574-0.755, p=0.001), a sensitivity of 60.9, and a specificity of 68.1. For PLR, Sensitivity and specificity were 72.5 and 58, respectively, with an AUC of 0.668(95% CI 0.577-0.758, p=0.001). With sensitivity and specificity of 66.7 and 62.3 respectively, SII had an AUC of 0.65(95% CI 0.558-0.743, p=0.002). SIRI, NLR and MLR did not demonstrate statistically significant differences between the groups(p>0.05). Conclusion: There was moderate correlation between the studied hematological indices and positive cultures, suggesting their potential role as inflammatory markers. Larger prospective trials should be conducted to further validate their potential clinical value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.